{"id":1204,"date":"2026-10-22T08:00:34","date_gmt":"2026-10-22T11:00:34","guid":{"rendered":"https:\/\/www.vitapharmaconsulting.com\/en\/?post_type=noticias&#038;p=1204"},"modified":"2026-10-21T18:16:42","modified_gmt":"2026-10-21T21:16:42","slug":"anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products","status":"publish","type":"noticias","link":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/10\/22\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\/","title":{"rendered":"ANVISA presents PONTE Project, a Pilot for Technical Interaction During the Quality Assessment of Medicinal Products"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">On July 23, 2026, ANVISA&#8217;s Medicinal Product Quality Assessment Unit (GQMED\/GGMED) presented the PONTE Project (Optimization Program through a Technical Clarification Core), a pilot initiative that creates a structured channel for technical interaction between the Agency and companies during the quality assessment of medicinal products. The information was released by ABIFINA (Brazilian Fine Chemicals, Biotechnology and Specialty Industries Association, acronym from the Portuguese <\/span><i><span style=\"font-weight: 400;\">Associa\u00e7\u00e3o Brasileira das Ind\u00fastrias de Qu\u00edmica Fina, Biotecnologia e suas Especialidades<\/span><\/i><span style=\"font-weight: 400;\">), which attended the presentation meeting.<\/span><\/p>\n<p><!--more--><\/p>\n<h2>What the project proposes<\/h2>\n<p><span style=\"font-weight: 400;\">The objective is to reduce deficiency letters arising from information asymmetries, such as unresolved technical questions or difficulty in locating, in the dossier, data that is already there. In this way, ANVISA intends to shorten assessment time and the number of deficiency letter cycles, without compromising technical rigor or the formality of the administrative process. Participation is voluntary and, at this stage, limited to companies invited by the Agency. The interaction takes place in a dedicated Microsoft Teams environment, organized around three main tools:<\/span><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Technical Contextualization Meetings: presentation of specific aspects of the dossier before or during the assessment.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Follow-up Channel: clarification of specific questions and location of information throughout the assessment.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Compliance Alignment Meetings: clarification of the deficiency letters issued, to reduce repeated deficiencies and improve the quality of responses.<\/span><\/li>\n<\/ul>\n<h2>What does not change<\/h2>\n<p><span style=\"font-weight: 400;\">ANVISA clarified that PONTE does not change the regulatory procedure or replace the formal submission of documents. At the end of the pilot, assessment time, the number of deficiency letters and the perception of participating companies will be evaluated, and these indicators will support a possible expansion of the initiative.<\/span><\/p>\n<h2>Interaction during the assessment at other authorities<\/h2>\n<p><span style=\"font-weight: 400;\">Dialogue between authority and applicant throughout the assessment is not new internationally, and agencies such as the FDA and the EMA provide for information requests and clarification meetings during the review. PONTE brings ANVISA closer to this approach, still on a small scale and keeping the formal assessment as the central step.<\/span><\/p>\n<h2>What this means for companies<\/h2>\n<p><span style=\"font-weight: 400;\">As the pilot is voluntary and limited to invited companies, most applicants will not yet have direct access to the channel. Even so, the design of the project indicates where the Agency identifies inefficiency: information that is in the dossier but hard to locate, and responses to deficiency letters that do not resolve the point raised and lead to new rounds. Dossiers with a clear structure, precise cross-references between modules and responses that point directly to the evidence are likely to benefit from this approach, with or without PONTE.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Vita supports companies in organizing dossiers and in preparing responses to quality deficiency letters, and follows the developments and possible expansion of the pilot.<\/span><\/p>\n","protected":false},"author":3,"featured_media":1205,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"_links_to":"","_links_to_target":""},"categorias":[22],"class_list":["post-1204","noticias","type-noticias","status-publish","has-post-thumbnail","hentry","categorias-brasil-anvisa"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ANVISA presents PONTE Project, a Pilot for Technical Interaction During the Quality Assessment of Medicinal Products - Vita<\/title>\n<meta name=\"description\" content=\"On July 23, 2026, ANVISA&#039;s Medicinal Product Quality Assessment Unit (GQMED\/GGMED) presented the PONTE Project (Optimization Program through a Technical Clarification Core), a pilot initiative that creates a structured channel for technical interaction between the Agency and companies during the quality assessment of medicinal products.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/10\/22\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANVISA presents PONTE Project, a Pilot for Technical Interaction During the Quality Assessment of Medicinal Products - Vita\" \/>\n<meta property=\"og:description\" content=\"On July 23, 2026, ANVISA&#039;s Medicinal Product Quality Assessment Unit (GQMED\/GGMED) presented the PONTE Project (Optimization Program through a Technical Clarification Core), a pilot initiative that creates a structured channel for technical interaction between the Agency and companies during the quality assessment of medicinal products.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/10\/22\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\/\" \/>\n<meta property=\"og:site_name\" content=\"Vita\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2026\/10\/VitaPharma-SITE-1024x512.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"512\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/10\\\/22\\\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\\\/\",\"url\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/10\\\/22\\\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\\\/\",\"name\":\"ANVISA presents PONTE Project, a Pilot for Technical Interaction During the Quality Assessment of Medicinal Products - Vita\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/10\\\/22\\\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/10\\\/22\\\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/VitaPharma-SITE.png\",\"datePublished\":\"2026-10-22T11:00:34+00:00\",\"description\":\"On July 23, 2026, ANVISA's Medicinal Product Quality Assessment Unit (GQMED\\\/GGMED) presented the PONTE Project (Optimization Program through a Technical Clarification Core), a pilot initiative that creates a structured channel for technical interaction between the Agency and companies during the quality assessment of medicinal products.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/10\\\/22\\\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/10\\\/22\\\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/10\\\/22\\\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/VitaPharma-SITE.png\",\"contentUrl\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/VitaPharma-SITE.png\",\"width\":1800,\"height\":900,\"caption\":\"ANVISA presents PONTE Project, a Pilot for Technical Interaction During the Quality Assessment of Medicinal Products\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/10\\\/22\\\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANVISA presents PONTE Project, a Pilot for Technical Interaction During the Quality Assessment of Medicinal Products\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/\",\"name\":\"Vita\",\"description\":\"Regulatory affairs &amp; consulting\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANVISA presents PONTE Project, a Pilot for Technical Interaction During the Quality Assessment of Medicinal Products - Vita","description":"On July 23, 2026, ANVISA's Medicinal Product Quality Assessment Unit (GQMED\/GGMED) presented the PONTE Project (Optimization Program through a Technical Clarification Core), a pilot initiative that creates a structured channel for technical interaction between the Agency and companies during the quality assessment of medicinal products.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/10\/22\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\/","og_locale":"pt_BR","og_type":"article","og_title":"ANVISA presents PONTE Project, a Pilot for Technical Interaction During the Quality Assessment of Medicinal Products - Vita","og_description":"On July 23, 2026, ANVISA's Medicinal Product Quality Assessment Unit (GQMED\/GGMED) presented the PONTE Project (Optimization Program through a Technical Clarification Core), a pilot initiative that creates a structured channel for technical interaction between the Agency and companies during the quality assessment of medicinal products.","og_url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/10\/22\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\/","og_site_name":"Vita","og_image":[{"width":1024,"height":512,"url":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2026\/10\/VitaPharma-SITE-1024x512.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/10\/22\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\/","url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/10\/22\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\/","name":"ANVISA presents PONTE Project, a Pilot for Technical Interaction During the Quality Assessment of Medicinal Products - Vita","isPartOf":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/10\/22\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\/#primaryimage"},"image":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/10\/22\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2026\/10\/VitaPharma-SITE.png","datePublished":"2026-10-22T11:00:34+00:00","description":"On July 23, 2026, ANVISA's Medicinal Product Quality Assessment Unit (GQMED\/GGMED) presented the PONTE Project (Optimization Program through a Technical Clarification Core), a pilot initiative that creates a structured channel for technical interaction between the Agency and companies during the quality assessment of medicinal products.","breadcrumb":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/10\/22\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/10\/22\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/10\/22\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\/#primaryimage","url":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2026\/10\/VitaPharma-SITE.png","contentUrl":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2026\/10\/VitaPharma-SITE.png","width":1800,"height":900,"caption":"ANVISA presents PONTE Project, a Pilot for Technical Interaction During the Quality Assessment of Medicinal Products"},{"@type":"BreadcrumbList","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/10\/22\/anvisa-presents-ponte-project-a-pilot-for-technical-interaction-during-the-quality-assessment-of-medicinal-products\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/"},{"@type":"ListItem","position":2,"name":"ANVISA presents PONTE Project, a Pilot for Technical Interaction During the Quality Assessment of Medicinal Products"}]},{"@type":"WebSite","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website","url":"https:\/\/www.vitapharmaconsulting.com\/en\/","name":"Vita","description":"Regulatory affairs &amp; consulting","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vitapharmaconsulting.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"}]}},"_links":{"self":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias\/1204","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/types\/noticias"}],"author":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/users\/3"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media\/1205"}],"wp:attachment":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media?parent=1204"}],"wp:term":[{"taxonomy":"categorias","embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/categorias?post=1204"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}